Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long‐time echocardiography follow‐up study
Identifieur interne : 000F75 ( Main/Exploration ); précédent : 000F74; suivant : 000F76Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long‐time echocardiography follow‐up study
Auteurs : José Pardos-Gea [Espagne] ; Gustavo Avegliano [Espagne] ; Arturo Evangelista [Espagne] ; Miguel Vilardell [Espagne] ; José Ordi-Ros [Espagne]Source :
- International Journal of Rheumatic Diseases [ 1756-1841 ] ; 2015-01.
Abstract
Aim: Non‐valvular cardiac disease in the antiphospholipid syndrome (APS) has been scanty studied. We wanted to assess the prevalence and evolution of left myocardial disease, pulmonary hypertension and intracardiac thrombi in a cohort of APS patients. Method: A total of 53 patients with APS, either primary (n = 34, 64%) or associated to lupus (n = 19, 36%) and 20 controls were included. Initial transthoracic echocardiography assessment was performed in patients at diagnosis, with echocardiography controls performed along mean follow‐up of 12 years. Prevalence of myocardial disease in APS cohort was assessed taking into account primary risk factors (hemodynamically significant valvular disease, systemic hypertension, diabetes, alcoholism, myocardial infarction or myocarditis), the same as for pulmonary hypertension (severe left ventricular dysfunction or chronic lung disease). Results: Left myocardial disease had a prevalence of 3.8% (2/53 patients), not different from controls (P = 0.12). Both patients had diastolic dysfunction grade I that maintained stability throughout echocardiographic follow‐up period. Pulmonary hypertension had a prevalence of 11.3% (6/53 patients), not different from controls (P = 0.12); all cases were related to pulmonary embolism. Patients diagnosed with pulmonary hypertension in baseline maintained stable pressures throughout follow‐up in the absence of new thrombosis. Intracardiac thrombi had a prevalence of 1.8% (1/53 patients), not different from controls (P = 0.4), without changes along echocardiographic follow‐up. Conclusion: Pulmonary hypertension is the most prevalent non‐valvular cardiac manifestation in APS, with an evolution associated with thromboembolic disease, while left myocardial disease and intracardiac thrombi would be rare manifestations in APS.
Url:
DOI: 10.1111/1756-185X.12191
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002401
- to stream Istex, to step Curation: 002401
- to stream Istex, to step Checkpoint: 000120
- to stream Main, to step Merge: 000F76
- to stream Main, to step Curation: 000F75
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long‐time echocardiography follow‐up study</title><author><name sortKey="Pardos Ea, Jose" sort="Pardos Ea, Jose" uniqKey="Pardos Ea J" first="José" last="Pardos-Gea">José Pardos-Gea</name></author><author><name sortKey="Avegliano, Gustavo" sort="Avegliano, Gustavo" uniqKey="Avegliano G" first="Gustavo" last="Avegliano">Gustavo Avegliano</name></author><author><name sortKey="Evangelista, Arturo" sort="Evangelista, Arturo" uniqKey="Evangelista A" first="Arturo" last="Evangelista">Arturo Evangelista</name></author><author><name sortKey="Vilardell, Miguel" sort="Vilardell, Miguel" uniqKey="Vilardell M" first="Miguel" last="Vilardell">Miguel Vilardell</name></author><author><name sortKey="Ordi Os, Jose" sort="Ordi Os, Jose" uniqKey="Ordi Os J" first="José" last="Ordi-Ros">José Ordi-Ros</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5349AD6FCA166B0360A2AB89DE985254FC4ED8BF</idno><date when="2015" year="2015">2015</date><idno type="doi">10.1111/1756-185X.12191</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-81SHLCPQ-7/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002401</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002401</idno><idno type="wicri:Area/Istex/Curation">002401</idno><idno type="wicri:Area/Istex/Checkpoint">000120</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000120</idno><idno type="wicri:doubleKey">1756-1841:2015:Pardos Ea J:cardiac:manifestations:other</idno><idno type="wicri:Area/Main/Merge">000F76</idno><idno type="wicri:Area/Main/Curation">000F75</idno><idno type="wicri:Area/Main/Exploration">000F75</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long‐time echocardiography follow‐up study</title><author><name sortKey="Pardos Ea, Jose" sort="Pardos Ea, Jose" uniqKey="Pardos Ea J" first="José" last="Pardos-Gea">José Pardos-Gea</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Research Unit for Autoimmune Diseases, Department of Internal Medicine, Vall d′Hebrón University Hospital, Universidad Autónoma de Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation><affiliation></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Espagne</country></affiliation></author><author><name sortKey="Avegliano, Gustavo" sort="Avegliano, Gustavo" uniqKey="Avegliano G" first="Gustavo" last="Avegliano">Gustavo Avegliano</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Echocardiography Unit, Department of Cardiology, Vall d′Hebrón University Hospital, Universidad Autónoma de Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Evangelista, Arturo" sort="Evangelista, Arturo" uniqKey="Evangelista A" first="Arturo" last="Evangelista">Arturo Evangelista</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Echocardiography Unit, Department of Cardiology, Vall d′Hebrón University Hospital, Universidad Autónoma de Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Vilardell, Miguel" sort="Vilardell, Miguel" uniqKey="Vilardell M" first="Miguel" last="Vilardell">Miguel Vilardell</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Research Unit for Autoimmune Diseases, Department of Internal Medicine, Vall d′Hebrón University Hospital, Universidad Autónoma de Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Ordi Os, Jose" sort="Ordi Os, Jose" uniqKey="Ordi Os J" first="José" last="Ordi-Ros">José Ordi-Ros</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Research Unit for Autoimmune Diseases, Department of Internal Medicine, Vall d′Hebrón University Hospital, Universidad Autónoma de Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">International Journal of Rheumatic Diseases</title><title level="j" type="alt">INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES</title><idno type="ISSN">1756-1841</idno><idno type="eISSN">1756-185X</idno><imprint><biblScope unit="vol">18</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="76">76</biblScope><biblScope unit="page" to="83">83</biblScope><biblScope unit="page-count">8</biblScope><date type="published" when="2015-01">2015-01</date></imprint><idno type="ISSN">1756-1841</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1756-1841</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Aim: Non‐valvular cardiac disease in the antiphospholipid syndrome (APS) has been scanty studied. We wanted to assess the prevalence and evolution of left myocardial disease, pulmonary hypertension and intracardiac thrombi in a cohort of APS patients. Method: A total of 53 patients with APS, either primary (n = 34, 64%) or associated to lupus (n = 19, 36%) and 20 controls were included. Initial transthoracic echocardiography assessment was performed in patients at diagnosis, with echocardiography controls performed along mean follow‐up of 12 years. Prevalence of myocardial disease in APS cohort was assessed taking into account primary risk factors (hemodynamically significant valvular disease, systemic hypertension, diabetes, alcoholism, myocardial infarction or myocarditis), the same as for pulmonary hypertension (severe left ventricular dysfunction or chronic lung disease). Results: Left myocardial disease had a prevalence of 3.8% (2/53 patients), not different from controls (P = 0.12). Both patients had diastolic dysfunction grade I that maintained stability throughout echocardiographic follow‐up period. Pulmonary hypertension had a prevalence of 11.3% (6/53 patients), not different from controls (P = 0.12); all cases were related to pulmonary embolism. Patients diagnosed with pulmonary hypertension in baseline maintained stable pressures throughout follow‐up in the absence of new thrombosis. Intracardiac thrombi had a prevalence of 1.8% (1/53 patients), not different from controls (P = 0.4), without changes along echocardiographic follow‐up. Conclusion: Pulmonary hypertension is the most prevalent non‐valvular cardiac manifestation in APS, with an evolution associated with thromboembolic disease, while left myocardial disease and intracardiac thrombi would be rare manifestations in APS.</div></front></TEI><affiliations><list><country><li>Espagne</li></country><region><li>Catalogne</li></region><settlement><li>Barcelone</li></settlement></list><tree><country name="Espagne"><region name="Catalogne"><name sortKey="Pardos Ea, Jose" sort="Pardos Ea, Jose" uniqKey="Pardos Ea J" first="José" last="Pardos-Gea">José Pardos-Gea</name></region><name sortKey="Avegliano, Gustavo" sort="Avegliano, Gustavo" uniqKey="Avegliano G" first="Gustavo" last="Avegliano">Gustavo Avegliano</name><name sortKey="Evangelista, Arturo" sort="Evangelista, Arturo" uniqKey="Evangelista A" first="Arturo" last="Evangelista">Arturo Evangelista</name><name sortKey="Ordi Os, Jose" sort="Ordi Os, Jose" uniqKey="Ordi Os J" first="José" last="Ordi-Ros">José Ordi-Ros</name><name sortKey="Pardos Ea, Jose" sort="Pardos Ea, Jose" uniqKey="Pardos Ea J" first="José" last="Pardos-Gea">José Pardos-Gea</name><name sortKey="Vilardell, Miguel" sort="Vilardell, Miguel" uniqKey="Vilardell M" first="Miguel" last="Vilardell">Miguel Vilardell</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F75 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000F75 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:5349AD6FCA166B0360A2AB89DE985254FC4ED8BF
|texte= Cardiac manifestations other than valvulopathy in antiphospholipid syndrome: long‐time echocardiography follow‐up study
}}
| This area was generated with Dilib version V0.6.33. |  |